ANVS compared with TNYA: revenue, margins and what each company keeps, and the suppliers and customers both name

ANVSAnnovis Bio, Inc.

Mkt capRevenueRevenue

TNYATenaya Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ANVSAnnovis Bio, Inc.

TNYATenaya Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ANVS1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±37.6%▼−5.95%×0.16

TNYA2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±79.4%▼−14.57%×0.18

Q2 FY26±51.0%▼−7.51%×0.15

= impliedANVS realized, solidTNYA realized, hatchedOne scale, both sides: full bar = 80%× = |realized| ÷ impliedSource: market data

ANVSAnnovis Bio, Inc.

0.82▲+23.07%· post 0.95

Mkt cap$36.0MRevenue—

TNYATenaya Therapeutics, Inc.

0.36▲+13.96%· post 0.36

ClosedNov 6 '26

Mkt cap$82.1MRevenue$2MQ3 FY26

Compare

ClosedNov 6 '26

ANVSAnnovis Bio, Inc.

TNYATenaya Therapeutics, Inc.

0.82▲+23.07%post 0.95

Price

0.36▲+13.96%post 0.36

$36.0M

Mkt cap

$82.1M

—

Revenue

$2MQ3 FY26

ANVS0.82▲+23.07%vsTNYA0.36▲+13.96%ClosedNov 6 '26